The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study

Abstract

The prevalence of anti-HCV(+) in HD has decreased markedly over the last decade in the participating units from most European countries. This decrease should reduce further the risk of nosocomial and occupational HCV infection in HD and ultimately contribute to improved long-term prognosis of HD patients and kidney graft recipients.